Table 1.

Patient characteristics at SCT and outcomes

Total number of survivors, n		109
Median age in years (range)	At SCT	34	(7–66)
Gender, n (%)	Males	62	(57%)
	Females	47	(43%)
Diagnosis at SCT, n (%)	CML	56	(51%)
	Acute leukemia	29	(27%)
	MDS	13	(12%)
	Others	11	(10%)
Conditioning intensity, n (%)	Fully ablative	99	(91%)
	Reduced intensity	10	(9%)
Graft source, n (%)	Bone marrow	15	(14%)
	Peripheral blood	94	(86%)
No. of survivors at follow-up, n (%)	5 years post-SCT	64	(59%)
	10 years post-SCT	45	(41%)
	5 and 10 years post-SCT	35	(32%)
Median age in years (range)	5 years post-SCT	40	(12–71)
	10 years post-SCT	46	(17–66)
Outcomes at time of analysis, n (%)	Alive	97	(89%)
	Deaths	12	(11%)
Causes of death, n (%)	Relapse	4	(33%)
	cGVHD with multi-organ failure	2	(17%)
	Secondary malignancy	2	(17%)
	Infection/sepsis	2	(17%)
	Brain hemorrhage	1	(8%)
	Respiratory failure	1	(8%)